References
- Meggiolaro A, Unim B, Semyonov L, Miccoli S, Maffongelli E, La Torre G. The role of Pap test screening against cervical cancer: a systematic review and meta-analysis. Clin Ter 2016; 167: 124-39. doi: 10.7417/CT.2016.1942
- Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer 2020; 127: 207-23. doi: 10.1016/j.ejca.2019.12.013
- Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. doi: 10.1515/raon-2017-0008
- National Cervical Cancer Screening Programme ZORA. DP ZORA: kazalniki. [internet]. [cited 2020 Jan 6]. Available at: https://zora.onko-i.si/publikacije/kazalniki/
- National Cervical Cancer Screening Programme ZORA. [internet]. [cited 2020 Jan 6]. Available at: https://zora.onko-i.si/
- Benett KF, Waller J, Chorley AJ, Ferrer RA, Haddrell JB, Marlow LAV. Barriers to cervical screening and interest in self-sampling among women who actively decline screening. Med Screen 2018; 25: 211-7. doi: 10.1177/0969141318767471
- Logan L, Mcilfatrick S. Exploring women’s knowledge, experiences and perceptions of cervical cancer screening in an area of social deprivation. Eur J Cancer Care 2011; 20: 720-7. doi: 10.1111/j.1365-2354.2011.01254.x
- Arbyn M, Ronco G, Anttila A, Meijer CJLM, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012; 30: 88-99. doi: 10.1016/j.vaccine.2012.06.095
- Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer 2015; 51: 2375-85. doi: 10.1016/j.ejca.2015.07.006
- Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Global Health 2019; 4: e001351. doi: 10.1136/bmjgh-2018-001351
- Arbyn M, Smith SB, Temin S, Sultana F, Castle P; Collaboration on Self-Sampling and HPV Testing. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ 2018; 363: k4823. doi: 10.1136/bmj.k4823
- Ivanus U, Jerman T, Fokter Repse A, Takac I, Prevodnik VK, Marcec M, et al. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Radiol Oncol 2018; 52: 399-412. doi: 10.2478/raon-2018-0036
- Guidelines for management of women with cervical precancerous lesions. Ursic-Vrscaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger I, editors. Ljubljana; Institute of Oncology Ljubljana; 2011. [internet]. [cited 2020 Jan 20]. Available at: https://zora.onko-i.si/fileadmin/user_upload/dokumenti/strokovna_priporocila/2011_Smernice_web.pdf
- R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020. [internet]. [cited 2020 Jan 20]. Available at: http://www.R-project.org/
- Jentschke M, Soergel P, Hillemanns P. Evaluation of multiplex real time PCR assay for the detection of human papillomavirus infection on self-colleceted cervicovaginal lavage samples. J Clin Virol 2013; 193: 131-4. doi: 10.1016/j.jviromet.2013.05.009
- Aiko KY, Yoko M, Saito OM, Ryoko A, Yasuyo M, Mikiko AS, et al. Accuracy of self-collected human papillomavirus samples from Japanese women with abnormal cervical cytology. J Obstet Gynaecol Res 2017; 43: 710-7. doi:org/10.1111/jog.13258
- Nobbenhuis MAE, Helmerhorst TJM, Van den Brule AJC, Rozendaal L, Jaspar LH, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002; 55: 435-9. doi: 10.1136/jcp.55.6.435
- Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal. Vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000: 163: 513-8. PMID: 11006761
- Jentschke M, Chen K, Arbyn M, Hertel B, Noskowicz M, Soergel P, et al. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections. J Clin Virol 2016; 82: 46-50. doi: 10.1016/j.jcv.2016.06.016
- Darlin L, Bergfeldt C. Forslund O, Hénic E, Dillner J, Kannisto P. Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity. J Clin Virol 2013; 56: 52-6. doi: 10.1016/j.jcv.2012.09.002
- Seo SS, Song YS, Kim JW, Park NH, Kang SB, Lee HP. Good correlation oh HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray. Gynecol Oncol 2006; 102: 67-73. doi: 10.1016/j.ygyno.2005.11.030
- Arbyn M, Verdoodt F, Snijeders PJF, Verhoef VMJ, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014; 15: 172-83. doi: 10.1016/S1470-2045(13)70570-9
- Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers DAM, Molijn AC, et al. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. Lancet Oncol 2019; 20: 229-38. doi: 10.1016/S1470-2045(18)30763-0
- El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb W, Hemnings R, et al. Validation of a new HPV self-sampling device for cervical cancer screening: the cervical and self-sample in screening (CASSIS) study. Gynecol Oncol 2018; 149: 491-7. doi: 10.1016/j.ygyno.2018.04.004
- Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, et al. Diagnostic accuracy of self-collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005; 8: 207-12. doi: 10.1136/sti.2004.011858
- Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007; 105: 530-5. doi: 10.1016/j.ygyno.2007.01.023
- Boggan JC, Walmer DK, Henderson G, Chakhtoura N, McCarthy SH, Beauvais HJ, et al. Vaginal self-sampling for human papillomavirus infection as a primary cervical cancer screening tool in a Haitian population. Sex Transm Dis 2015; 42: 655-9. doi: 10.1097/OLQ.0000000000000345
- Leinonen MK, Schee K, Jonassen CM, Lie AK, Nystrand CF, Rangberg A, et al. Safety and acceptability of human papillomavirus testing of self-collected specimens: a methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions. J Clin Virol 2017; 9: 22-30. doi: 10.1016/j.jcv.2017.12.008
- Toliman P, Badman SG, Gabuzzi J, Silim S, Forereme L, Kumbia A, et al. Field evaluation of Xpert HPV point-of-care test for detection of human papillomavirus infection by use of self-collected vaginal and clinician-collected cervical specimens. J Clin Microbiol 2016; 54: 1734-7. doi: 10.1128/JCM.00529-16
- Obiri-Yeboah D, Adu-Sarkodie Y, Djigma F, Hayfron-Benjamin A, Abdul L, Simpore J, et al. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women. BMC Womens Health 2017; 17: 86. doi: 10.1186/s12905-017-0448-1
- Ketelaars PJW, Bosgraaf RP, Siebers AG, Massuger LFAG, van der Linden JC, Wauters CAP, et al. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: results of the VERA study. Prev Med 2017; 101: 96-101. doi: 10.1016/j.ypmed.2017.05.021
- El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, et al. Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions. Cancer Epidemiol Biomark Prev 2019; 28: 1134-40. doi: 10.1158/1055-9965.EPI-18-1338
- Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev 2017; 8: CD008587. doi: 10.1002/14651858.CD008587.pub2
- Castanov A, Landy R, Michalopoulos D, Bhudia R, Leaver H, Qiao YL, et al. Systematic review and meta-analysis of individual patient data to assess the sensitivity of cervical cytology for diagnosis of cervical cancer in low-and middle-income countries. J Glob Oncol 2017; 3: 524-38. doi: 10.1200/JGO.2016.008011
- Pesic A, Krings A, Hempel M, Preyer R, Chatzistamatius K, Agorastos T, et al. CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology. Virol J 2019; 16: 92. doi: 10.1186/s12985-019-1197-6
- Polman NJ, Snijders PJF, Kenter GG, Berkhof J, Meijer CJLM. HPV-based cervical screening: rationale, expectations and future perspectives of the new Dutch screening programme Prev Med 2019; 119: 108-17. doi: /10.1016/j.ypmed.2018.12.021
- Rebolj M, Rimmer J, Denton K, Tidy J, Mathev C, Ellis K, et al. Primary cervical screening with high risk human papillomavirus testing: observational study. BMJ 2019; 364: 240. doi: https://doi.org/10.1136/bmj.l240
- von Karsa L, Arbyn M, De Vuyst H, Dillner J, Dillner L, Franchesci S, et al. European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Papillomavirus Res 2015; 1: 22-31. doi: /10.1016/j.pvr.2015.06.006
- Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. New Technologies for Cervical Cancer screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57. doi: 10.1016/S1470-2045(09)70360-2
- Hermansson RS, Olovsson M, Hoxell E, Lindström AK. HPV prevalence and HPV-related dysplasia in elderly women. PLoS One 2018; 13: e0189300. doi: 10.1371/journal.pone.0189300
- Lindström AK, Hermansson RS, Gustavsson I, Hedlund Lindberg J, Gyllensten U, Olovsson M. Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing. PLoS One 2018; 13: e0207714. doi: 10.1371/journal.pone.0207714